Results 141 to 150 of about 3,566 (207)

[Oliguria and rise in creatine phosphokinase as a side-effect of citalopram]. [PDF]

Aten Primaria, 2004
Vich Pérez P, Ruiz Arribas C, Collados Navas R, Pastor-Sánchez R.   +3 more
europepmc   +1 more source

Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? [PDF]

Dialogues Clin Neurosci, 2006
Geyer MA.
europepmc   +1 more source

20193. OREJA AZUL: UN SIGNO DE TOXICIDAD POR CLOZAPINA

Neurology Perspectives
D. González Antón, L. Vela Desojo, C. Ruiz López, M. Barcenilla López, J. Contreras Peña, N. de la Cruz Fernández, B. Arribas Ballesteros, P. Colligris Micheralaki, A. de la Torre Pérez, A. Méndez Valdés, F. Pinedo Moraleja, R. López Blanco   +11 more
doaj   +1 more source

[Assessment of websites with information on medicines]. [PDF]

Aten Primaria, 2009
Pernett JJ, Gutiérrez JF, Tamayo CB, Castro MM, Tuneu i Valls L.   +4 more
europepmc   +1 more source

[The use of neuromodulation for the treatment of tremor]. [PDF]

Surg Neurol Int, 2014
Bendersky D, Ajler P, Yampolsky C.
europepmc   +1 more source

Clinical predictors of therapeutic response to antipsychotics in schizophrenia. [PDF]

Dialogues Clin Neurosci, 2014
Carbon M, Correll CU.
europepmc   +1 more source

Miocarditis. [PDF]

Medicine (Baltimore), 2001
Pérez-Villa F.
europepmc   +1 more source

Receptors heteromèrics com a diana terapèutica en l'esquizofrènia [PDF]

, 2014
Martí Malgosa, Mariona, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Factores de riesgo cardiovascular en el trastorno mental severo [PDF]

, 2013
Guillot, Maria Verónica, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina   +2 more
core